Stocktoria
SkinHealth Systems Inc. SKIN
SkinHealth Systems Inc. financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $300.8M | $334.3M | $398.0M | $365.9M | $260.1M | $119.1M |
| Gross profit | $196.4M | $182.3M | $155.1M | $248.8M | $178.5M | $67.2M |
| R&D expense | $5.6M | $6.3M | $10.1M | $8.4M | $8.2M | $3.4M |
| Operating income | -$20.8M | -$67.8M | -$130.9M | -$25.8M | -$39.9M | -$17.2M |
| Interest expense | — | — | $13.6M | $13.4M | $11.8M | — |
| Income tax | $3.6M | -$452,000 | -$1.8M | $1.1M | -$1.9M | -$9.3M |
| Net income | -$9.5M | -$29.1M | -$100.1M | $44.2M | -$378.8M | -$29.2M |
| EPS (diluted) | $-0.16 | $-0.36 | $-0.76 | $-0.23 | $-3.71 | $-0.85 |
| Operating cash flow | $37.5M | $16.1M | $21.8M | -$106.6M | -$28.4M | -$12.4M |
| Free cash flow | $37.2M | $15.4M | $17.9M | -$117.4M | -$39.6M | -$15.9M |
| Cash & equivalents | — | — | $523.0M | $568.2M | $901.9M | $9.5M |
| Inventory | $48.0M | $69.1M | $91.3M | $109.7M | $35.3M | $23.2M |
| Total assets | $499.8M | $685.7M | $929.1M | $1.0B | $1.2B | $222.8M |
| Total liabilities | $438.7M | $633.9M | $869.7M | $836.0M | $916.5M | $252.8M |
| Shareholders' equity | $61.1M | $51.8M | $59.4M | $167.1M | $298.0M | -$30.6M |
Growth · year-over-year · Revenue CAGR 20.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue growth | -10.0% | -16.0% | +8.8% | +40.7% | +118.4% | — |
| Net income growth | — | — | -326.4% | — | — | — |
| Free cash flow growth | +141.8% | -14.2% | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.